Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Application

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 12 > >>
EC Number Application Commentary Reference
Show all pathways known for 1.14.19.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.1agriculture disease resistance 437672
Show all pathways known for 1.14.19.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.1agriculture higher enzymic acitivity in Jersey-sired cattle than in Limousin-sired cattle, positive relationship between adipose tissue beta-carotene and desaturation 659832
Show all pathways known for 1.14.19.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.1drug development isozyme SCD1 may represent a therapeutic target to control obesity and the progression of related metabolic diseases including type 2 diabetes and hepatic steatosis 746542
Show all pathways known for 1.14.19.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.1drug development SCD-1 is a promising target for the treatment of cancer, skin disorders and metabolic diseases, development of clinical drug candidates 744416
Show all pathways known for 1.14.19.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.1medicine DELTA9 desaturase and abdominal adiposity are positively associated independently of insulin resistance and dietary saturated fatty acids intake, DELTA9 desaturase is positively associated with blood lipids independent of the insulin resistance, abdominal adiposity, and dietary saturated fatty acid intake 699984
Show all pathways known for 1.14.19.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.1medicine isozyme SCD1 may represent a therapeutic target to control obesity and the progression of related metabolic diseases including type 2 diabetes and hepatic steatosis 746542
Show all pathways known for 1.14.19.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.1medicine potential use of SCD1 as a target in the treatment of some eye diseases 437671
Show all pathways known for 1.14.19.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.1medicine targeting SCD1 in combination with sorafenib may be another therapeutic strategy against liver cancer. SCD1 may be a biomarker for sorafenib response and personalized medicine for hepatocellular carcinoma 745482
Show all pathways known for 1.14.19.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.1medicine the gene combination of macrophage migration inhibitory factor and stearoyl-CoA desaturase 1 is a prognostic marker for the overall outcome of soft tissue sarcomas 728632
Show all pathways known for 1.14.19.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.19.1medicine treatment with enzyme-specific antisense oligonucleotide inhibitors results in prevention of diet-induced obesity with reductions in the ratio of oleate to stearoyl-CoA in tissues and plasma. Correlation with reduced body adiposity, hepatomegaly and steatosis 659574
Results 1 - 10 of 12 > >>